The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Share News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LiDCO To Report Fall In Revenue After Transition To HUP Business Model

Wed, 20th Feb 2019 11:57

LONDON (Alliance News) - LiDCO Group PLC on Wednesday said it expects to report a double-ditgit decline in revenue in its recently ended financial year as it transitions its clients to the newly launched HUP business model.

The hemodynamic monitoring company said it continues to make progress with its HUP offering. As of Tuesday, LiDCO said it had a total global contracted base of 191 HUP monitors, up from 96 reported at the end of January 2018. Revenue from annualised HUP contracts totalled GBP1.5 million, more than doubled from GBP730,000 a year prior.

Overall, LiDCO said its product revenue for the year to January 31 was GBP6.2 million, down from GBP6.9 million a year earlier, while total revenue, which includes third party products, was GBP7.3 million, also lower than GBP8.3 million in financial 2018.

In the US, the strong growth of HUP meant that recurring revenue, which includes per patient disposables and service contracts, grew nearly 50% compared with the prior year to GBP1.3 million from GBP850,000.

Meanwhile, in the UK, LiDCO was focused on a conversion of its largest customers to the HUP business model, which had a transitional impact on the company's sales revenue recognition within the financial year. As a result, sales in the final quarter were less than the usual peak and LiDCO product revenue for financial 2019 were GBP3.6 million, down from GBP4.1 million a year ago.

LiDCO revenue outside of the UK and US markets in financial 2019 were GBP1.3 million, down slightly from GBP1.4 million the year before. The company explained that strong revenue growth in Japan and preliminary orders from new distribution channels in Europe were offset by weaker demand from the Middle East region.

Looking ahead, the company said it continues to invest in geographical expansion, applying for several regulatory registrations in key target markets in South East Asia and Latin America.

The company intends to announce its results for the year on March 26.

"Whilst the transition to the HUP business model has a short-term effect of deferring sales, we are encouraged by the progress made having built a recurring revenue base of over GBP1.5 million in just 18 months from launch of the HUP business model," said Chief Executive Matt Sassone.

"With continued focus on LiDCO's HUP model, we are well-placed to grow the business in line with our objectives over the short to medium term," added Sassone.

LiDCO shares were trading 1.2% higher on Wednesday at 4.40 pence each.

More News
12 Feb 2014 10:53

LiDCO Expects To Swing To Pretax Profit In Full Year, As Expected

LONDON (Alliance News) - LiDCO Group PLC Wednesday said it expects pretax profit for the year ended January 31 to be in line with expectations, compared with a loss of GBP260,000 a year earlier. In a trading update ahead of its full-year results, the cardiovascular monitoring company said r

Read more
12 Feb 2014 08:25

UK MORNING BRIEFING: Telecity Drops 13% As Market Awaits BOE

LONDON (Alliance News) - Shares have opened mostly flat Wednesday, as the market awaits the Bank of England's Quarterly Inflation Report at 1030 GMT.

Telecity is holding back the FTSE 250. The data-centre provider is down 13% after announcing higher 2013 profit and

Read more
1 Oct 2013 08:47

LiDCO cash-flow positive as losses come down in first half

Surgical blood monitoring group LiDCO said it expected to be cash generative and profitable in the full year after slashing losses in the first half. Chief Executive Officer Terry O'Brien said the company had seen significant sales growth in the UK and export markets in the six months to end-July

Read more
26 Sep 2013 08:18

LiDCO Granted Graphical User Interface Patent By US Patent Office

Read more
4 Sep 2013 10:35

LiDCO receives approval from FDA

LiDCO, a cardiovascular monitoring company, said Wednesday that the US Food and Drug Administration (FDA) has cleared its CNSystems' continuous non-invasive blood pressure monitoring module for sale. The software enables the connection of modules to the LiDCOrapid cardiac output monitor allowing i

Read more
4 Sep 2013 09:13

LiDCo Says Blood Pressure System Using Its Montior Gets FDA Clearance

Read more
4 Sep 2013 08:18

STOCKS NEWS EUROPE-UK small caps outperform wider market

UK small caps and junior-listed AIM shares trade flat and up 0.1 percent respectively, outperforming the wider market where the mid-caps shed 0.6 percent and the blue chips trade 0.2 percent weaker. AIM-listed cardiovascular monitoring firm LiDCO Group advances almost 5 percent after the c

Read more
5 Jun 2013 16:09

STOCKS NEWS EUROPE-UK small caps fall less than broader market

The FTSE small-cap index and the junior FTSE Alternative Investment Market (AIM) all-share index both end 1.3 percent lower, outperforming a 1.8 percent fall for the mid caps and a 2.1 percent drop on the blue chips. Shares in VPhase fall 44 percent to 0.26 pence as the AIM-listed energy ef

Read more
5 Jun 2013 12:30

LiDCO surges on positive clinical trials

AIM-listed cardiovascular monitoring company LiDCO Group, has revealed that its LiDCOrapid blood monitoring system has been used successfully to monitor patients having major liver surgery. The hemodynamic system monitored cardiac output and guided intravenous fluid therapy in a randomised clinica

Read more
17 Dec 2012 07:45

LiDCO drives US expansion

Cardiovascular monitoring company LiDCO confirmed that it has acquired the existing LiDCOrapid customer base from Covidien, its previous US distribution partner, as it beefs up commercial opportunities in the US. After an initial integration and switch-over period the group expects associated rev

Read more
23 Aug 2012 16:00

Small caps round-up: Infrastructure India, SkyePharma, LiDCO Group

Infrastructure India, an AIM-listed investment group, pleased its investors with a 50.2 per cent leap in its net asset value (NAV) to 207.3m pounds over the year ended March. The value of the company's investments rose 94.9 per cent to 216.7m pounds, while the NAV per share climbed from 92p to 95p.

Read more
24 Apr 2012 15:52

LiDCO posts maiden profit

LiDCO, the blood movement monitoring company, announced its maiden post-tax profit although phasing issues with a major customer meant the numbers were not as impressive as the market had been expecting. The company made a loss of £45,000 before tax in the year to January 31st, versus a loss of £49

Read more
27 Oct 2011 06:54

Thursday tips round-up: BATs, CSR, Lidco...

British American Tobacco, the world's second-biggest maker of cigarettes, yesterday delivered a smoking set of results for the first nine months of this year, writes the Investment Column in the Independent. The volume of cigarettes sold by the group slipped by 0.4 per cent but BAT's ability to push

Read more
23 Aug 2011 13:58

LiDCO's sales to grow 18%

Cardiovascular monitoring company LiDCO expects revenue in the six months ended 31 July to be 18% ahead of the first half of 2010. The firm predicts sales to be at least £3.1m, compared to the £2.66m reported the year before, while losses are said to have been "significantly reduced". Pre-tax losse

Read more
20 Jul 2011 17:04

Premier Farnell director buys after shares wither

Premier Farnell non-executive director Paul Withers has taken advantage of a recent weak spell in the electrical components and industrial products supplier's share price, spending nearly £55,000. He took 30,000 shares at 183p a go, and now has 70,000. Shares in Premier Farnell took a dive earlier

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.